Mid Atlantic Bio Angels
Angel Group/Syndicate
Active
New York, United States
22
2M
16
3
0.27
- Stages of investment
- Areas of investment
Summary
This organization was formed by Stephen Goodman, Yaniv Sneor.
The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Mid Atlantic Bio Angels, startups are often financed by Robin Hood Ventures, Minority Angel Investor Network, Life Sciences Greenhouse of Pennsylvania. The meaningful sponsors for the fund in investment in the same round are New York Angels, Keiretsu Forum, The North West Fund. In the next rounds fund is usually obtained by ic@3401, Keiretsu Forum Northwest, BioAdvance.
Among the most popular portfolio startups of the fund, we may highlight Immunomic Therapeutics, New View Surgical, Inc.. The fund has no exact preference in a number of founders of portfolio startups. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most popular fund investment industries, there are Biopharma, Software.
The top activity for fund was in 2013. The typical startup value when the investment from Mid Atlantic Bio Angels is 1-5 millions dollars. Deals in the range of 1 - 5 millions dollars are the general things for fund. The fund is constantly included in less than 2 deals per year.
Investor highlights
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 22
- Lead investments
- 3
- Follow on index
- 0.27
- Investments by industry
- Biotechnology (14)
- Health Care (11)
- Medical Device (10)
- Medical (7)
- Therapeutics (5) Show 14 more
- Investments by region
-
- United States (18)
- Israel (2)
- France (1)
- United Kingdom (1)
- Peak activity year
- 2017
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Avg. valuation at time of investment
- 1M
- Group Appearance index
- 0.59
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Astrocyte Pharmaceuticals | 03 May 2021 | Biotechnology, Pharmaceutical, Therapeutics, Clinical Trials | Early Stage Venture | 6M | United States, Massachusetts, Cambridge |
| RailWatch | 31 May 2020 | Information Technology, Artificial Intelligence, Machine Learning, Big Data, Internet of Things, Predictive Analytics, Test and Measurement, Industrial Automation, Railroad | Seed | 8M | North Rhine-Westphalia, Bonn, Germany |
| The Shape Sensing Company | 10 Nov 2022 | Wellness, Medical Device, Sensor | Seed | United States, Texas, Austin |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.